STOCK TITAN

VTEX director exercises options, sells 199K shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

VTEX director Francisco Alvarez-Demalde reported the exercise of 182,000 stock options held for the benefit of Riverwood Capital GP II Ltd. and/or certain affiliates on November 9, 2026, at a $3.55 exercise price, acquiring 182,000 Class A common shares. The Riverwood-benefit holdings included sales of 182,000 and 16,640 Class A shares at a weighted average $3.90 per share; sale prices ranged from $3.90 to $3.925. The fully vested options had been extended until November 13, 2026, and sale proceeds are to be transferred as directed by Riverwood.

Insider Alvarez-Demalde Francisco
Role Director
Sold 198,640 shs ($775K)
Approx. gross sale proceeds $775K
Approx. exercise cost $646K
Share of Position Sold 100%
Type Security Shares Price Value
In-the-Money Exercise Stock Options F3, F1 182,000 $0.00 $0.00
In-the-Money Exercise Class A Common Shares F1 182,000 $3.55 $646K
Sale Class A Common Shares F2, F1 182,000 $3.90 $710K
Sale Class A Common Shares F2, F1 16,640 $3.90 $65K
Holdings After Transaction: Stock Options — 0 options (Direct); Class A Common Shares — 0 shares (Direct)
Holdings Before and After: Stock Options, 182,000 to 0 options (Direct); Class A Common Shares, 16,640 to 0 shares (Direct)
Other Insiders: 3 other insiders reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (3)
  1. F1. These securities are held by Mr. Alvarez-Demalde for the benefit of Riverwood Capital GP II Ltd. and/or certain of its affiliates (collectively, "Riverwood"). Mr. Alvarez-Demalde is obligated to transfer the underlying shares upon settlement or any proceeds from the sale thereof as directed by Riverwood. Mr. Alvarez-Demalde disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities by Mr. Alvarez-Demalde for purposes of Section 16 or any other purposes.
  2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from USD $3.90 to USD $3.925, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  3. F3. These stock options are fully vested. Exercise of these stock options were extended until November 13, 2026.
Stock options exercised 182,000 stock options November 9, 2026
Exercise price $3.55 per share Stock options exercised November 9, 2026
Total shares sold 198,640 shares Two sale transactions on November 9, 2026
Weighted average sale price $3.90 per share Sale transactions on November 9, 2026
Sale price range $3.90 to $3.925 per share Multiple transactions; inclusive
Stock options following transaction 0 stock options Reported position after the November 9, 2026 exercise
Extended exercise period Until November 13, 2026 Fully vested stock options
fully vested financial
"These stock options are fully vested."
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
in-the-money or at-the-money derivative security financial
"Exercise of in-the-money or at-the-money derivative security"
beneficial ownership regulatory
"disclaims beneficial ownership of these securities"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
foreign private issuer regulatory
"Issuer's status as a foreign private issuer"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many VTEX shares did Francisco Alvarez-Demalde sell?

Sales for the benefit of Riverwood Capital GP II Ltd. and/or certain affiliates covered 182,000 and 16,640 Class A shares on November 9, 2026. Each sale row reported a weighted average price of $3.90 per share; the shares were sold in multiple transactions ranging from $3.90 to $3.925, inclusive.

How many VTEX options were exercised, and at what price?

182,000 fully vested stock options were exercised at a $3.55 exercise price on November 9, 2026. The reported stock-option position following the exercise was zero, and the exercise period had been extended until November 13, 2026.

Who benefited from the VTEX shares and sale proceeds?

The securities were held by Francisco Alvarez-Demalde for the benefit of Riverwood Capital GP II Ltd. and/or certain affiliates. He was obligated to transfer the underlying shares upon settlement or any sale proceeds as directed by Riverwood.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Alvarez-Demalde Francisco

(Last)(First)(Middle)
C/O RIVERWOOD CAPITAL MANAGEMENT L.P.,
70 WILLOW ROAD, SUITE 200

(Street)
MENLO PARK CALIFORNIA 94025

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
VTEX [ NYSE: VTEX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/09/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Shares11/09/2026X182,000A$3.55198,640D(1)
Class A Common Shares11/09/2026S182,000D$3.9(2)16,640D(1)
Class A Common Shares11/09/2026S16,640D$3.9(2)0D(1)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options$3.5511/09/2026X182,000 (3) (3)Class A Common Shares182,000$00D(1)
Explanation of Responses:
1. These securities are held by Mr. Alvarez-Demalde for the benefit of Riverwood Capital GP II Ltd. and/or certain of its affiliates (collectively, "Riverwood"). Mr. Alvarez-Demalde is obligated to transfer the underlying shares upon settlement or any proceeds from the sale thereof as directed by Riverwood. Mr. Alvarez-Demalde disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities by Mr. Alvarez-Demalde for purposes of Section 16 or any other purposes.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from USD $3.90 to USD $3.925, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
3. These stock options are fully vested. Exercise of these stock options were extended until November 13, 2026.
Remarks:
Due to the Issuer's status as a foreign private issuer pursuant to Rule 3a12-3(b) under the Securities Exchange Act of 1934 (the "Act"), the reporting person's transactions in the Issuer's equity securities are exempt from Sections 16(b) and 16(c) of the Act.
/s/ Francisco Alvarez-Demalde11/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading